Huntington National Bank Axsome Therapeutics, Inc. Transaction History
Huntington National Bank
- $13.8 Billion
- Q4 2024
A detailed history of Huntington National Bank transactions in Axsome Therapeutics, Inc. stock. As of the latest transaction made, Huntington National Bank holds 214 shares of AXSM stock, worth $26,771. This represents 0.0% of its overall portfolio holdings.
Number of Shares
214
Previous 215
0.47%
Holding current value
$26,771
Previous $19,000
5.26%
% of portfolio
0.0%
Previous 0.0%
Shares
16 transactions
Others Institutions Holding AXSM
# of Institutions
351Shares Held
36.3MCall Options Held
1.77MPut Options Held
1.16M-
Rtw Investments, LP New York, NY4.05MShares$507 Million5.59% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.9MShares$488 Million0.01% of portfolio
-
Black Rock Inc. New York, NY3.3MShares$413 Million0.01% of portfolio
-
Fairmount Funds Management LLC Philadelphia, PA1.47MShares$184 Million24.98% of portfolio
-
Bvf Inc San Francisco, CA1.39MShares$174 Million4.4% of portfolio
About Axsome Therapeutics, Inc.
- Ticker AXSM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 42,878,000
- Market Cap $5.36B
- Description
- Axsome Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel therapies for central nervous system (CNS) disorders in the United States. The company's product pipeline includes AXS-05, a therapeutic for the treatment of major depressive disorder and resistant depression disorders; and that is in the Phase III clinic...